ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 271 filers reported holding ALKERMES PLC in Q3 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,602,018 | -35.8% | 557,016 | -28.2% | 0.01% | -30.0% |
| Q2 2023 | $24,295,373 | +91.5% | 776,210 | +72.5% | 0.01% | +100.0% |
| Q1 2023 | $12,685,077 | +148.2% | 449,985 | +130.1% | 0.01% | +150.0% |
| Q4 2022 | $5,110,532 | +17.3% | 195,581 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $4,356,000 | -25.0% | 195,081 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $5,811,000 | +13.2% | 195,081 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $5,133,000 | -5.3% | 195,081 | -16.3% | 0.00% | 0.0% |
| Q4 2021 | $5,419,000 | -10.9% | 232,981 | +18.2% | 0.00% | 0.0% |
| Q3 2021 | $6,081,000 | +24.9% | 197,181 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $4,869,000 | +254.9% | 198,581 | +170.5% | 0.00% | +100.0% |
| Q1 2021 | $1,372,000 | -5.8% | 73,426 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $1,457,000 | +18.6% | 73,026 | -1.6% | 0.00% | 0.0% |
| Q3 2020 | $1,229,000 | -25.2% | 74,176 | -12.4% | 0.00% | 0.0% |
| Q2 2020 | $1,643,000 | +26.2% | 84,676 | -6.2% | 0.00% | 0.0% |
| Q1 2020 | $1,302,000 | -30.8% | 90,276 | -2.2% | 0.00% | 0.0% |
| Q4 2019 | $1,882,000 | +14.0% | 92,276 | +9.0% | 0.00% | 0.0% |
| Q3 2019 | $1,651,000 | -13.5% | 84,633 | +0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,908,000 | -38.5% | 84,631 | -0.4% | 0.00% | -50.0% |
| Q1 2019 | $3,102,000 | +21.6% | 85,013 | -1.6% | 0.00% | 0.0% |
| Q4 2018 | $2,550,000 | -31.9% | 86,410 | -2.0% | 0.00% | 0.0% |
| Q3 2018 | $3,743,000 | -0.7% | 88,206 | -3.6% | 0.00% | -33.3% |
| Q2 2018 | $3,768,000 | -32.4% | 91,542 | -4.8% | 0.00% | -25.0% |
| Q1 2018 | $5,573,000 | +4.4% | 96,160 | -1.4% | 0.00% | 0.0% |
| Q4 2017 | $5,338,000 | -23.7% | 97,530 | -29.1% | 0.00% | -20.0% |
| Q3 2017 | $6,998,000 | +23.0% | 137,640 | +40.2% | 0.01% | +25.0% |
| Q2 2017 | $5,689,000 | +0.4% | 98,140 | +1.3% | 0.00% | -20.0% |
| Q1 2017 | $5,667,000 | +5.3% | 96,865 | +0.1% | 0.01% | +25.0% |
| Q4 2016 | $5,380,000 | +14.9% | 96,802 | -2.8% | 0.00% | 0.0% |
| Q3 2016 | $4,684,000 | +7.6% | 99,597 | -1.1% | 0.00% | 0.0% |
| Q2 2016 | $4,354,000 | +24.8% | 100,731 | -1.3% | 0.00% | +33.3% |
| Q1 2016 | $3,490,000 | -66.3% | 102,081 | -21.7% | 0.00% | -66.7% |
| Q4 2015 | $10,354,000 | +33.4% | 130,442 | -1.4% | 0.01% | +28.6% |
| Q3 2015 | $7,762,000 | -13.8% | 132,294 | -5.5% | 0.01% | 0.0% |
| Q2 2015 | $9,006,000 | +7.2% | 139,970 | +1.6% | 0.01% | 0.0% |
| Q1 2015 | $8,403,000 | +8.4% | 137,820 | +4.1% | 0.01% | +16.7% |
| Q4 2014 | $7,751,000 | +36.1% | 132,360 | -0.4% | 0.01% | +20.0% |
| Q3 2014 | $5,696,000 | -17.2% | 132,860 | -2.8% | 0.01% | -16.7% |
| Q2 2014 | $6,880,000 | +24.3% | 136,700 | +8.9% | 0.01% | +20.0% |
| Q1 2014 | $5,536,000 | -17.2% | 125,551 | -23.6% | 0.01% | -16.7% |
| Q4 2013 | $6,686,000 | +14.0% | 164,440 | -5.7% | 0.01% | 0.0% |
| Q3 2013 | $5,866,000 | +51.5% | 174,470 | +29.3% | 0.01% | +50.0% |
| Q2 2013 | $3,871,000 | – | 134,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |